RGX-200

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRGX-200
Drug Alias Namesmall-molecule (RemeGenix)RGX-200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRemeGenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRemeGenix Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A